So, How Fast is Your LC/MS Analysis?apps.thermoscientific.com/media/cmd/hypersite... · RT: 0.00 -...

45
The world leader in serving science Pittcon John Fink So, How Fast is Your LC/MS Analysis?

Transcript of So, How Fast is Your LC/MS Analysis?apps.thermoscientific.com/media/cmd/hypersite... · RT: 0.00 -...

  • 1 The world leader in serving science

    Pittcon John Fink

    So, How Fast is Your LC/MS Analysis?

  • 2

    So, How Fast is Your LC/MS Analysis?

    • We will shows examples of…

    • Ultra-fast LC/MS solutions

    • Ultra-fast LC/MS • Pharma and Clinical Research applications • Chromatography only and ultra-fast online clean-up

  • 3

    Benefits of Ultra-Fast LC/MS

    • Get results sooner

    • Get more data in same or shorter time

    • Save money

    • Potential to save solvents • Free up capacity on expensive equipment

  • 4

    Obstacles of Ultra-Fast LC/MS

    • Is your equipment even robust enough?

    • Was it designed to run 24/7? • Are you overstressing it, require constant maintenance?

    • Will data quality be sacrificed by going faster? • Expensive to buy additional systems for more capacity

  • 5

    Solution – Multi-Channel LCUltra-Fast Throughput

    • Multiple, independent, but parallel LC channels

    • All separate, but flow into one mass spec detector

    • Time staggered injections, so no data is ever missed

  • 6

    Multi-Channel LC Technology

    • All channels are independent • Separate pumps, injectors, tubing, columns

    • Time staggering, valve switching all effortlessly controlled by user-friendly software

  • 7

    Method and Gradient Example – LC-MS

    0 min 4 min

    Acquisition: compounds elute to MS during this 45s window

    gradient

  • 8

    Multi-Channel LC Increases Throughput

    All coordinated and controlled by Thermo Scientific™ Aria™ software

    System diagram above is representative of a Thermo Scientific™ Transcend™ LX-4 system

    1 min 4 min.

    Syst

    em

    1

    3 min .

    4 min .

    2 min

    Syst

    em

    2 Sy

    stem

    3

    Each LC system only requires the MS during

    the elution step

    Idle Time

    Acquisition Window

    Idle Time

    Syst

    em

    4

  • 9

    Syst

    em

    4

    Multi-Channel LC Example – 4 LC Channels

    0 min

    Syst

    em

    1

    2 min

    3 min

    1 min

    Syst

    em

    2 Sy

    stem

    3

    0 min

    During this 4 min window – 4 samples were completed

    Equals 60 samples/hour versus 15 samples/hour (without Multiplexing)

    Final Collected MS Data

    Individual data files

    Staggered Injections

  • 10

    Data on LX-4 System – Compare Method Data Window

    1 LC

    LX-4

    3.75 samples in the time it takes to run 1 sample

  • 11

    Multiple Method Ultra-Throughput

    Two methods running simultaneously

    0 min 3 min.

    0 min 3 min.

    Syst

    em

    1 Method 1

    Method 2

    0 min 3 min.

    MS Data – Multiplexed

    System diagram above is representative of a Transcend LX-2 system

    Syst

    em

    2

  • 12

    Multi-Channel LC with Aria Software

    1. Import or Create a batch/sequence of samples

    2. Select which LC channel(s) to run the samples or select “Any Available”

    3. Submit batch!

    More batches can be submitted at any time in any order and the system will automatically multiplex where possible.

  • 13

    Benefits of Multi-Channel LC

    • Accelerate results • Getting answers/data faster

    Throughput

    Less Cost

    Flexibility

    Ease of Use

    • Handles multiple methods • Many options available

    • Intuitive, quick learning curve

    • Reduce cost of capital equipment • Reduce cost per sample

  • 14 The world leader in serving science

    Case Study – High Throughput QQQ Screening

  • 15

    High Throughput Screening Application

    • Equipment • Transcend LX-4 System 4-Channel LC • Aria OS software • Thermo Scientific™ TSQ Vantage™ mass spectrometer

    • Application • Four-channel LC separation for high-throughput, simultaneous

    analysis of a compound of interest for drug discovery • Compound: 1-minute method with a 15-second data collection window

    • Same method runs on separate channels, simultaneously

    • Quadruple throughput

    Chromatography is performed in this short time !

  • 16

    HTS, 15s Injections – Throughput RT: 0.00 - 139.82

    0 20 40 60 80 100 120Time (min)

    0

    20

    40

    60

    80

    100

    0

    20

    40

    60

    80

    100

    Relative A

    bundance

    0

    20

    40

    60

    80

    100

    RT: 120.78AA: 136RT: 23.46

    AA: 120

    RT: 113.27AA: 95.09

    RT: 14.83AA: 91.95

    RT: 31.00AA: 91.17 RT: 126.91

    AA: 81.14RT: 48.24AA: 68.21

    RT: 100.64AA: 68.13

    RT: 67.22AA: 55.48

    RT: 36.73AA: 56.75

    RT: 87.66AA: 52.46

    120.77

    RT: 120.78AA: 6352RT: 23.46

    AA: 5456

    RT: 14.83AA: 4177

    RT: 113.27AA: 4494

    RT: 31.00AA: 4038 RT: 126.91

    AA: 3452RT: 48.24AA: 2949

    RT: 68.30AA: 2997

    RT: 13.74AA: 3002

    RT: 100.64AA: 2868

    RT: 36.73AA: 2483

    RT: 87.66AA: 2369

    NL: 3.31E3TIC MS ICIS SPL1_Well_001

    NL: 9.86E2TIC F: - c ESI SRM ms2 403.500 [151.500-152.500] MS SPL1_Well_001

    NL: 3.31E3TIC F: - c ESI SRM ms2 417.500 [151.500-152.500] MS ICIS SPL1_Well_001

    RT: 43.98 - 55.62

    44 45 46 47 48 49 50 51 52 53 54 55Time (min)

    0

    20

    40

    60

    80

    100

    0

    20

    40

    60

    80

    100

    Relative A

    bundance

    0

    20

    40

    60

    80

    100

    RT: 48.24AA: 68.21RT: 47.16

    AA: 62.70RT: 48.25AA: 49.29

    RT: 46.79AA: 50.86 RT: 51.09

    AA: 41.83

    RT: 48.22AA: 1109 RT: 51.48

    AA: 1026RT: 47.15AA: 930 RT: 50.00

    AA: 864RT: 48.92AA: 771 RT: 52.54AA: 725RT: 53.63AA: 744

    RT: 44.62AA: 721

    RT: 45.70AA: 711

    RT: 54.72AA: 652

    RT: 48.24AA: 2949RT: 47.16

    AA: 2753 RT: 50.01AA: 2408RT: 46.79

    AA: 2221RT: 44.63AA: 2066RT: 48.94AA: 2072

    RT: 52.89AA: 1993

    RT: 50.42AA: 1878

    RT: 53.64AA: 1834

    RT: 51.09AA: 1787 RT: 54.73

    AA: 1488RT: 45.71AA: 1546

    NL: 1.62E3TIC MS ICIS SPL1_Well_001

    NL: 6.18E2TIC F: - c ESI SRM ms2 403.500 [151.500-152.500] MS ICIS SPL1_Well_001

    NL: 1.62E3TIC F: - c ESI SRM ms2 417.500 [151.500-152.500] MS ICIS SPL1_Well_001

  • 17

    Ultra-Fast LC/MS

    • Able to screen 384 well plate (384 samples) in 96 minutes

    • 24 plate capacity

    • Redundant systems

    • Intelligent software

  • 18 The world leader in serving science

    Example – High Resolution Accurate Mass Drug Discovery Workflows

  • 19

    Transcend II LX-4 UHPLC System with Q Exactive MS

  • 20

    Transcend II, LX-4 System Hardware

    • Four Thermo Scientific™ Dionex™ UltiMate™ 3000 HPG-3400RS pumps

    • Dual-arm CTC autosampler with DLW • Transcend II VIM with selector and detector

    bypass valves

  • 21

    LC Method and Sample - 4 Lipids

    • Four lipids in a 100ng/mL neat standard (Lipid 862 used as IS) • BEH C8, 2.1x50 mm, 1.7 μm columns • MP A: 5mM Ammonium Formate + 0.2% Formic Acid (aq) • MP B: 5mM Ammonium Formate + 0.2% Formic Acid in 1:1 ACN:MeOH

    Before LC Method Optimization: Constant 0.750 mL/min Flow Rate Loading at 10:90 A:B Step Gradient to 5:95 A:B Re-equilibration back to 10:90 A:B Elution within a ~36s data window 5-μL 100% organic sample injection

    After LC Method Optimization: Variable 1 – 0.5 mL/min Flow Rate Loading at 10:90 A:B Step Gradient to 5:95 A:B Re-equilibration back to 10:90 A:B Elution within a 21s data window 10-μL 90% organic sample injection

  • 22

    3 Method Trials

    Test #

    Data Window

    (secs)

    # of

    Injections

    % RSD

    (peak area ratio)

    1

    21

    (multiple data files)

    1000

    3.94 (L_806) 2.93 (L_890) 2.55 (L_888)

    2

    21

    (single data file)

    384 x 3

    5.83 (L_806) 4.52 (L_890) 4.34 (L_888)

    3

    9

    (single data file)

    384

    2.84 (L_888)

  • 23

    C:\Xcalibur\...\Sample001 11/14/13 11:30:06 Sample001N/CRT: 0.00 - 176.59 SM: 5G

    0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170Time (min)

    0

    100

    0

    100

    0

    100

    0

    100

    RT: 46.05AA: 26337SN: 310

    RT: 0.50AA: 35391SN: 309

    RT: 62.61AA: 29960SN: 298

    RT: 64.44AA: 27658SN: 298

    RT: 40.53AA: 28248SN: 292

    RT: 25.81AA: 29567SN: 290

    RT: 120.10AA: 28013SN: 267

    RT: 96.18AA: 27267SN: 259

    RT: 90.66AA: 22590SN: 258

    RT: 155.08AA: 25839SN: 254

    RT: 13.39AA: 26323SN: 254

    RT: 162.44AA: 25516SN: 253

    RT: 107.24AA: 24086SN: 253

    RT: 132.99AA: 24979SN: 248

    RT: 147.72AA: 26397SN: 247

    RT: 42.51AA: 99948SN: 440

    RT: 57.24AA: 105250SN: 431

    RT: 62.76AA: 99856SN: 422

    RT: 27.80AA: 96168SN: 406

    RT: 143.23AA: 80268SN: 384

    RT: 163.47AA: 79306SN: 382

    RT: 0.65AA: 113228SN: 377

    RT: 150.59AA: 77699SN: 372

    RT: 95.38AA: 76662SN: 366

    RT: 121.14AA: 75790SN: 365

    RT: 86.19AA: 78012SN: 363

    RT: 71.46AA: 76807SN: 360

    RT: 115.62AA: 75443SN: 359

    RT: 137.72AA: 75846SN: 357

    RT: 18.11AA: 78468SN: 355

    RT: 46.28AA: 291648SN: 408

    RT: 62.85AA: 295440SN: 405

    RT: 38.93AA: 286329SN: 395

    RT: 0.30AA: 311812SN: 374

    RT: 26.05AA: 280182SN: 362

    RT: 69.71AA: 237171SN: 361

    RT: 143.31AA: 222421SN: 356

    RT: 119.39AA: 221149SN: 354

    RT: 95.47AA: 221198SN: 354

    RT: 167.23AA: 219008SN: 341

    RT: 158.04AA: 220406SN: 341

    RT: 88.12AA: 221427SN: 340

    RT: 112.04AA: 216178SN: 339

    RT: 130.44AA: 217567SN: 337

    RT: 16.36AA: 224530SN: 321

    RT: 46.19AA: 671315SN: 1931

    RT: 62.76AA: 648226SN: 1865

    RT: 38.84AA: 655611SN: 1846

    RT: 27.80AA: 645725SN: 1760

    RT: 69.63AA: 539813SN: 1723

    RT: 0.65AA: 716499SN: 1667

    RT: 143.23AA: 515626SN: 1635

    RT: 176.36AA: 499585SN: 1620

    RT: 163.47AA: 503520SN: 1603

    RT: 119.30AA: 495420SN: 1602

    RT: 91.71AA: 502366SN: 1591

    RT: 97.23AA: 496196SN: 1572

    RT: 137.72AA: 492410SN: 1567

    NL: 3.54E4m/z= 806.54173-806.54979 MS ICIS Sample001

    NL: 9.64E4m/z= 862.60405-862.61267 MS ICIS Sample001

    NL: 2.39E5m/z= 890.63521-890.64411 MS ICIS Sample001

    NL: 6.05E5m/z= 888.61957-888.62845 MS ICIS Sample001

    RT: 103.06 - 104.81 SM: 5G

    103.1 103.2 103.3 103.4 103.5 103.6 103.7 103.8 103.9 104.0 104.1 104.2 104.3 104.4 104.5 104.6 104.7 104.8Time (min)

    0

    100

    0

    100

    0

    100

    0

    100

    RT: 103.10AA: 24554SN: 239

    RT: 104.45AA: 19941SN: 239

    RT: 103.56AA: 27204SN: 234

    RT: 104.02AA: 24515SN: 220

    RT: 104.59AA: 75250SN: 335

    RT: 103.24AA: 75603SN: 321

    RT: 103.70AA: 86764SN: 304

    RT: 104.16AA: 77207SN: 293 RT: 104.54

    AA: 8014SN: 40

    RT: 103.65AA: 11077SN: 39

    RT: 103.19AA: 7985SN: 34

    RT: 104.68AA: 217095SN: 310

    RT: 103.34AA: 219431SN: 293

    RT: 104.25AA: 219845SN: 261

    RT: 103.80AA: 241909SN: 258

    RT: 104.62AA: 96459SN: 151

    RT: 103.27AA: 93813SN: 145

    RT: 104.19AA: 99221SN: 136

    RT: 103.73AA: 104726SN: 135

    RT: 104.59AA: 493233SN: 1473

    RT: 103.25AA: 497242SN: 1417

    RT: 103.70AA: 552731SN: 1311

    RT: 104.16AA: 485637SN: 1253

    NL: 2.67E4m/z= 806.54173-806.54979 MS ICIS Sample001

    NL: 7.35E4m/z= 862.60405-862.61267 MS ICIS Sample001

    NL: 1.82E5m/z= 890.63521-890.64411 MS ICIS Sample001

    NL: 4.62E5m/z= 888.61957-888.62845 MS ICIS Sample001

    Single Data File (21s DW) 384 Sample Injections

  • 24

    384 Sample Injections – Individual Data Files (Four-Channel View) – 21 Second Data Window

    C:\Xcalibur\...\4_data2088 11/09/13 15:32:38

    RT: 0.00 - 0.35 SM: 5G

    0.0 0.1 0.2 0.3Time (min)

    0

    20

    40

    60

    80

    100

    Rel

    ativ

    e A

    bund

    ance

    0

    20

    40

    60

    80

    100

    Rel

    ativ

    e A

    bund

    ance

    0

    20

    40

    60

    80

    100

    Rel

    ativ

    e A

    bund

    ance

    0

    20

    40

    60

    80

    100

    Rel

    ativ

    e A

    bund

    ance

    RT: 0.04AA: 27179SN: 229

    RT: 0.18AA: 83182SN: 347

    RT: 0.13AA: 12136SN: 48

    RT: 0.28AA: 224310SN: 157

    RT: 0.18AA: 203454SN: 93

    RT: 0.18AA: 532936SN: 639

    NL:2.49E4m/z= 806.53769-806.55383 MS ICIS 4_data2086

    NL:6.26E4m/z= 862.59973-862.61699 MS ICIS 4_data2086

    NL:1.51E5m/z= 890.63075-890.64857 MS ICIS 4_data2086

    NL:4.04E5m/z= 888.61512-888.63290 MS ICIS 4_data2086

    RT: 0.00 - 0.35 SM: 5G

    0.0 0.1 0.2 0.3Time (min)

    0

    20

    40

    60

    80

    100

    Rel

    ativ

    e A

    bund

    ance

    0

    20

    40

    60

    80

    100

    Rel

    ativ

    e A

    bund

    ance

    0

    20

    40

    60

    80

    100R

    elat

    ive

    Abu

    ndan

    ce

    0

    20

    40

    60

    80

    100

    Rel

    ativ

    e A

    bund

    ance

    RT: 0.04AA: 25789SN: 583

    RT: 0.18AA: 77733SN: 311

    RT: 0.13AA: 8129SN: 34

    RT: 0.27AA: 229836SN: 389

    RT: 0.18AA: 213530SN: 206

    RT: 0.18AA: 521225SN: 1697

    NL:2.71E4m/z= 806.53769-806.55383 MS ICIS 4_data2087

    NL:7.70E4m/z= 862.59973-862.61699 MS ICIS 4_data2087

    NL:1.94E5m/z= 890.63075-890.64857 MS ICIS 4_data2087

    NL:4.78E5m/z= 888.61512-888.63290 MS ICIS 4_data2087

    RT: 0.00 - 0.35 SM: 5G

    0.0 0.1 0.2 0.3Time (min)

    0

    20

    40

    60

    80

    100

    Rel

    ativ

    e A

    bund

    ance

    0

    20

    40

    60

    80

    100

    Rel

    ativ

    e A

    bund

    ance

    0

    20

    40

    60

    80

    100

    Rel

    ativ

    e A

    bund

    ance

    0

    20

    40

    60

    80

    100

    Rel

    ativ

    e A

    bund

    ance

    RT: 0.04AA: 27309SN: 157

    RT: 0.18AA: 79992SN: 276

    RT: 0.13AA: 11192SN: 36

    RT: 0.27AA: 232939SN: 327

    RT: 0.18AA: 201548SN: 189

    RT: 0.16AA: 4355SN: 19

    RT: 0.18AA: 530499SN: 2007

    NL:2.63E4m/z= 806.53769-806.55383 MS ICIS 4_data2088

    NL:6.33E4m/z= 862.59973-862.61699 MS ICIS 4_data2088

    NL:1.50E5m/z= 890.63075-890.64857 MS ICIS 4_data2088

    NL:4.03E5m/z= 888.61512-888.63290 MS ICIS 4_data2088

    RT: 0.00 - 0.35 SM: 5G

    0.0 0.1 0.2 0.3Time (min)

    0

    20

    40

    60

    80

    100

    Rel

    ativ

    e A

    bund

    ance

    0

    20

    40

    60

    80

    100

    Rel

    ativ

    e A

    bund

    ance

    0

    20

    40

    60

    80

    100

    Rel

    ativ

    e A

    bund

    ance

    0

    20

    40

    60

    80

    100

    Rel

    ativ

    e A

    bund

    ance

    RT: 0.04AA: 27309SN: 157

    RT: 0.18AA: 79992SN: 276

    RT: 0.13AA: 11192SN: 36

    RT: 0.27AA: 232939SN: 327

    RT: 0.18AA: 201548SN: 189

    RT: 0.16AA: 4355SN: 19

    RT: 0.18AA: 530499SN: 2007

    NL:2.63E4m/z= 806.53769-806.55383 MS ICIS 4_data2088

    NL:6.33E4m/z= 862.59973-862.61699 MS ICIS 4_data2088

    NL:1.50E5m/z= 890.63075-890.64857 MS ICIS 4_data2088

    NL:4.03E5m/z= 888.61512-888.63290 MS ICIS 4_data2088

  • 25

    File (9 sec Data Window) 384 Sample Injections – Single Data

    E:\Q-Exactive Data\...\Sample1537 11/21/2013 3:17:55 PM Sample1537N/C

    RT: 0.00 - 107.25 SM: 5G

    0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105Time (min)

    0

    50

    100

    Relat

    ive A

    bund

    ance

    0

    50

    100

    Relat

    ive A

    bund

    ance

    RT: 50.96AA: 110520SN: 363

    RT: 63.28AA: 108578SN: 348

    RT: 91.24AA: 96646SN: 329

    RT: 66.64AA: 94929SN: 325

    RT: 87.88AA: 93785SN: 324

    RT: 0.68AA: 102558SN: 319

    RT: 75.59AA: 93956SN: 318

    RT: 9.64AA: 96896SN: 314

    RT: 95.19AA: 92747SN: 311

    RT: 23.56AA: 91786SN: 306

    RT: 44.26AA: 92712SN: 306

    RT: 101.37AA: 90521SN: 305

    RT: 16.34AA: 95527SN: 302

    RT: 26.92AA: 91004SN: 302

    RT: 37.58AA: 88315SN: 291

    RT: 50.97AA: 703842SN: 1949

    RT: 58.81AA: 674847SN: 1875

    RT: 63.29AA: 695572SN: 1870

    RT: 0.68AA: 665874SN: 1756

    RT: 87.89AA: 603052SN: 1741

    RT: 75.60AA: 608291SN: 1697

    RT: 9.64AA: 622674SN: 1686

    RT: 16.35AA: 634708SN: 1674

    RT: 26.35AA: 583436SN: 1661

    RT: 93.48AA: 589245SN: 1651

    RT: 44.26AA: 597256SN: 1650

    RT: 101.37AA: 576524SN: 1640

    RT: 31.40AA: 592022SN: 1619

    NL:9.95E4m/z= 862.59973-862.61699 M S ICIS Sample1537

    NL:6.13E5m/z= 888.61512-888.63290 M S ICIS Sample1537

    RT: 53.13 - 54.13 SM: 5G

    53.2 53.3 53.4 53.5 53.6 53.7 53.8 53.9 54.0 54.1Time (min)

    0

    50

    100

    Relat

    ive A

    bund

    ance

    0

    50

    100

    Relat

    ive A

    bund

    ance

    RT: 53.21AA: 96067SN: 311

    RT: 53.82AA: 78593SN: 259

    RT: 54.07AA: 80310SN: 236RT: 53.52

    AA: 69825SN: 151

    RT: 53.16AA: 9375SN: 31

    RT: 54.02AA: 9340SN: 28

    RT: 53.77AA: 9827SN: 28

    RT: 53.46AA: 7692SN: 17

    RT: 53.21AA: 605017SN: 1626

    RT: 53.82AA: 494857SN: 1347

    RT: 54.07AA: 523323SN: 1297RT: 53.52

    AA: 448931SN: 829

    NL:8.52E4m/z= 862.59973-862.61699 M S ICIS Sample1537

    NL:5.11E5m/z= 888.61512-888.63290 M S ICIS Sample1537

    Scaling to one-minute RT: 53.13 – 54.13 mins.

  • 26

    Four LC Channels Running….

  • 27

    Aria OS Batch File Viewer: Pressure Trace Overlay

  • 28

    Aria OS Batch Status View

  • 29

    Overview of Acquisition Styles – 384 Samples/Batch

    Acquisition Style

    Data Window Length (secs)

    LC Method Length (mins)

    Chromatography Batch Run Time (mins) Injections per minute

    Standard LC/MS w/ 384

    Data Files

    N/A

    1.6

    Baseline separation of 3

    Analytes

    ~614.4

    0.63

    LX-4 Multiplexing & 384 Data Files

    21

    1.6

    Baseline separation of 3

    Analytes

    222.74

    1.7

    LX-4 Multiplexing & One Data File

    21

    1.6

    Baseline separation of 3

    Analytes

    176.59

    2.2

    LX-4 Multiplexing & One Data File

    9

    1.0

    Co-Elution of 2

    Analytes

    107.25

    4.0

  • 30 The world leader in serving science

    Ultrafast Screening of Antiretrovirals: TurboFlow Technology and Multi-Channel LC

  • 31

    LC System

    • Transcend LX-2 system • Two channels

  • 32

    LC Method View

  • 33

    AS Method View

  • 34

    LCMS Method Details

    • Transcend LX-2 system with CTC single-arm DLW • Thermo Scientific™ TurboFlow™ column (0.5x50 mm) used in 1D setup • Analytical column: single guard column located at MS source • Mobile Phases:

    1. 10 mM Ammonium Formate w/ 0.05% Formic Acid (Loading) 2. Acetonitrile w/ 0.1% Formic Acid (Eluting) 3. 45:45:10 Acetonitrile:Isopropanol:Acetone (TurboFlow column wash)

    • Injection volume: 30 μL • LC Method Length: 100 seconds • Thermo Scientific™ Q Exactive™ MS with HESI source • Warfarin used as both Positive and Negative ESI mode IS • 30 sec MS data window necessary for simultaneous Positive/Negative switching • Use of Detector ByPass to allow for high flow rates of TurboFlow technology • Multiplexing sample clean-up yet singular analytical separation

  • 35

    TurboFlow Technology for Fast Online Clean Up

    • TurboFlow technology can eliminate off-line sample prep • Directly inject biological or dirty matrices • Typically used in 2D-LC • Improve data quality by reducing ion suppression and interferences

    • Uses • Size exclusion

    • Large molecules are not retained and go directly to waste • Do not have time to diffuse with high flow rates

    • Chemistry • Capture analytes with affinity for column’s stationary phase

    − Retain targeted analytes

    • Result • Rapid, automated, sample cleanup of unwanted large molecules and

    retention of specific analytes of interest

  • 36

    Standard Curve Comparisons In Three Matrices

    • ACN Std curve – diluted 1:3 with aqueous IS solution

    • Plasma Std curve – diluted 1:3 with aqueous IS solution

    • Plasma Std curve – crashed 1:3 with ACN IS solution

    • Whole Blood Std curve – crashed 1:3 with ACN IS solution

  • 37

    Nevirapine: ACN Standard Curve

  • 38

    Nevirapine: Plasma Dilution Standard Curve

  • 39

    Nevirapine: Plasma ACN-Crashed Standard Curve

  • 40

    Nevirapine: Whole Blood ACN-Crashed Curve

  • 41

    250 ng/mL Standard Comparison Across Four Matrix Preps (Full MS)

    Diluted ACN ACN-crashed Plasma Diluted Plasma

    ACN-crashed Whole Blood

    Nevirapine [M+H]+

    Saquinavir [M+H]+

    Zidovudine [M-H]-

    Efavirenz [M-H]-

    C:\Xcalibur\...\StdA_250_003 6/18/2013 6:02:47 PMJHopkins Plasma Curve w/ Warf and Morph-d3 IS added (Water dilution)RT: 0.00 - 0.53 SM: 7G

    0.0 0.2 0.4Time (min)

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    RT: 0.25AA: 84262314

    RT: 0.28AA: 276689068

    RT: 0.24AA: 41758

    RT: 0.37AA: 6864606

    RT: 0.34AA: 147554194

    RT: 0.05AA: 658433

    RT: 0.35AA: 132197193

    NL: 1.54E7m/z= 267.12326-267.12594 F: FTMS + p ESI Full ms [250.00-700.00] MS ICIS StdA_250_004

    NL: 4.90E7m/z= 671.38819-671.39491 F: FTMS + p ESI Full ms [250.00-700.00] MS ICIS StdA_250_004

    NL: 8.93E3m/z= 266.08815-266.09081 F: FTMS - p ESI Full ms [250.00-350.00] MS ICIS StdA_250_004

    NL: 1.37E6m/z= 314.01854-314.02168 F: FTMS - p ESI Full ms [250.00-350.00] MS ICIS StdA_250_004

    NL: 2.87E7m/z= 309.11059-309.11369 F: FTMS + p ESI Full ms [250.00-700.00] MS ICIS StdA_250_004

    NL: 2.24E7m/z= 307.09604-307.09912 F: FTMS - p ESI Full ms [250.00-350.00] MS ICIS StdA_250_004

    RT: 0.00 - 0.52 SM: 7G

    0.0 0.2 0.4Time (min)

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    RT: 0.29AA: 26676271

    RT: 0.29AA: 131704845

    RT: 0.24MA: 96299

    RT: 0.36AA: 3693436

    RT: 0.33AA: 14888169

    RT: 0.18AA: 33359

    RT: 0.34AA: 193817363

    RT: 0.13AA: 67616

    NL: 5.59E6m/z= 267.12326-267.12594 F: FTMS + p ESI Full ms [250.00-700.00] MS ICIS StdA_250_003

    NL: 2.82E7m/z= 671.38819-671.39491 F: FTMS + p ESI Full ms [250.00-700.00] MS ICIS StdA_250_003

    NL: 1.97E4m/z= 266.08815-266.09081 F: FTMS - p ESI Full ms [250.00-350.00] MS StdA_250_003

    NL: 7.60E5m/z= 314.01854-314.02168 F: FTMS - p ESI Full ms [250.00-350.00] MS ICIS StdA_250_003

    NL: 3.49E6m/z= 309.11059-309.11369 F: FTMS + p ESI Full ms [250.00-700.00] MS ICIS StdA_250_003

    NL: 3.51E7m/z= 307.09604-307.09912 F: FTMS - p ESI Full ms [250.00-350.00] MS ICIS StdA_250_003

    RT: 0.00 - 0.52 SM: 7G

    0.0 0.2 0.4Time (min)

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    RT: 0.25AA: 22978793

    RT: 0.29AA: 83570949

    RT: 0.03AA: 45509

    RT: 0.24AA: 16730

    RT: 0.36AA: 3235427

    RT: 0.31AA: 51351138

    RT: 0.34AA: 175642230

    NL: 4.78E6m/z= 267.12326-267.12594 F: FTMS + p ESI Full ms [250.00-700.00] MS ICIS StdA_250_004

    NL: 1.74E7m/z= 671.38819-671.39491 F: FTMS + p ESI Full ms [250.00-700.00] MS ICIS StdA_250_004

    NL: 3.82E3m/z= 266.08815-266.09081 F: FTMS - p ESI Full ms [250.00-350.00] MS ICIS StdA_250_004

    NL: 6.82E5m/z= 314.01854-314.02168 F: FTMS - p ESI Full ms [250.00-350.00] MS ICIS StdA_250_004

    NL: 1.19E7m/z= 309.11059-309.11369 F: FTMS + p ESI Full ms [250.00-700.00] MS ICIS StdA_250_004

    NL: 3.16E7m/z= 307.09604-307.09912 F: FTMS - p ESI Full ms [250.00-350.00] MS ICIS StdA_250_004

    RT: 0.00 - 0.52 SM: 7G

    0.0 0.2 0.4Time (min)

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    0

    20

    40

    60

    80

    100

    Rela

    tive

    Abun

    danc

    e

    RT: 0.25AA: 19856397

    RT: 0.29AA: 48388013

    RT: 0.26AA: 15227

    RT: 0.36AA: 3068603

    RT: 0.31AA: 64432405

    RT: 0.34AA: 215104504

    RT: 0.13AA: 98765

    NL: 4.15E6m/z= 267.12326-267.12594 F: FTMS + p ESI Full ms [250.00-700.00] MS ICIS StdA_250_004

    NL: 9.82E6m/z= 671.38819-671.39491 F: FTMS + p ESI Full ms [250.00-700.00] MS ICIS StdA_250_004

    NL: 3.29E3m/z= 266.08815-266.09081 F: FTMS - p ESI Full ms [250.00-350.00] MS ICIS StdA_250_004

    NL: 6.49E5m/z= 314.01854-314.02168 F: FTMS - p ESI Full ms [250.00-350.00] MS ICIS StdA_250_004

    NL: 1.46E7m/z= 309.11059-309.11369 F: FTMS + p ESI Full ms [250.00-700.00] MS ICIS StdA_250_004

    NL: 3.86E7m/z= 307.09604-307.09912 F: FTMS - p ESI Full ms [250.00-350.00] MS ICIS StdA_250_004

  • 42

    Antiretroviral Throughput with Online Cleanup

    • Ultra-fast throughput was achieved by three things… • Using TurboFlow technology for Quick-Elute fast online clean-up

    • Multi-channel LC enabled us to run four samples at a time • Allowing four samples in the time of one typical UHPLC sample

    • The Q Exactive MS enabled full-scan, accurate mass

  • 43

    Thermo Scientific Transcend II LX-4 Platform

    • Capable of standard method development and HPLC/UHPLC

    or a high-throughput workflow

    • Four LC systems utilize one mass spec

    • Single data file or multiple data files

    • Software tools for troubleshooting

    • Rugged, easy-to-maintain LC solution

    Fast Workflow-Driven Versatile User-Friendly Cost-Effective

  • 44

    Q Exactive MS: The Ultimate Routine Quan/Qual LC-MS/MS Instrument

    • Ideal QUANT + QUAL routine solution with highest quantification capabilities and identification confidence

    • Sensitivity: ~ high-end triple quadrupole mass spec

    • Mass Accuracy: 3 ppm external calibration, 1ppm internal calibration for at least one week

    • Resolution: 140K resolution

    • Speed: 12Hz @ 17.5K, 7Hz @ 35K, 3Hz @ 70K. No loss in sensitivity.

    • Scan-to-scan Polarity Switching: 1Hz @ 35K

    • Spectrum Multiplexing and All Ion Fragmentation

    • MS/MS or MS3: HCD with precursor or in-source CID

  • 45

    Summary – So, How Fast is Your LC/MS Analysis?

    • Demonstrated ultra-fast LC/MS • Pharma and Clinical Research applications • Chromatography alone and TurboFlow technology for ultra-fast online

    clean-up

    • Transcend systems drastically increase throughput, while keeping costs low

    • Robustness is maintained since systems are not overstressed

    • Take your best LC method and run it on a Transcend system to increase throughput

    So, How Fast is Your LC/MS Analysis?So, How Fast is Your LC/MS Analysis?Benefits of Ultra-Fast LC/MSObstacles of Ultra-Fast LC/MSSolution – Multi-Channel LCUltra-Fast ThroughputMulti-Channel LC TechnologyMethod and Gradient Example – LC-MSMulti-Channel LC Increases ThroughputMulti-Channel LC Example – 4 LC ChannelsData on LX-4 System – Compare Method Data WindowMultiple Method Ultra-ThroughputMulti-Channel LC with Aria Software Benefits of Multi-Channel LCCase Study – High Throughput QQQ ScreeningHigh Throughput Screening ApplicationHTS, 15s Injections – ThroughputUltra-Fast LC/MSExample – High Resolution Accurate Mass Drug Discovery WorkflowsTranscend II LX-4 UHPLC System with Q Exactive MSTranscend II, LX-4 System HardwareLC Method and Sample - 4 Lipids 3 Method TrialsSingle Data File (21s DW) 384 Sample Injections384 Sample Injections – Individual Data Files �(Four-Channel View) – 21 Second Data WindowFile (9 sec Data Window) �384 Sample Injections – Single DataFour LC Channels Running….Aria OS Batch File Viewer: Pressure Trace OverlayAria OS Batch Status ViewOverview of Acquisition Styles – 384 Samples/BatchUltrafast Screening of Antiretrovirals: �TurboFlow Technology and �Multi-Channel LCLC SystemLC Method ViewAS Method ViewLCMS Method DetailsTurboFlow Technology for Fast Online Clean UpStandard Curve Comparisons In Three MatricesNevirapine: ACN Standard CurveNevirapine: Plasma Dilution Standard CurveNevirapine: Plasma ACN-Crashed Standard Curve Nevirapine: Whole Blood ACN-Crashed Curve 250 ng/mL Standard Comparison Across Four Matrix Preps (Full MS) Antiretroviral Throughput with Online Cleanup Thermo Scientific Transcend II LX-4 PlatformQ Exactive MS: The Ultimate Routine Quan/Qual LC-MS/MS InstrumentSummary – So, How Fast is Your LC/MS Analysis?